Levothyroxine Glenmark Pharmaceuticals Europe (Levothyroxine Sodium)

Levothyroxine sodium is a synthetic form of the natural hormone T4. After oral absorption, it is converted to the active hormone T3, which binds nuclear thyroid receptors. This binding regulates gene expression that controls basal metabolic rate, protein synthesis, and energy utilization, thereby compensating for insufficient endogenous thyroid hormone.

The appropriate dose of Levothyroxine Glenmark is individualized and set by a qualified prescriber based on the patient’s age, weight, severity of thyroid deficiency, and laboratory thyroid function tests. Dosing is adjusted over time to achieve target TSH levels and clinical stability.

Levothyroxine is generally considered safe in pregnancy and lactation when clinically indicated, as untreated hypothyroidism can harm both mother and fetus. Dosage may need adjustment during pregnancy, and the prescriber should monitor thyroid function closely. Breastfeeding mothers should also be monitored, but the drug is excreted in low amounts in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Levothyroxine is the standard synthetic form of T4 and is preferred for most patients because it closely mimics natural thyroxine, has a long half‑life, and allows stable dosing. Alternatives such as liothyronine (synthetic T3) act more rapidly but require more frequent dosing and monitoring. Combination therapy may be used in select cases, but levothyroxine remains the first‑line treatment for hypothyroidism.

Levothyroxine tablets should be stored at temperatures below 25 °C in their original packaging. Protect them from moisture, excessive heat and direct sunlight. Do not store in bathrooms or near kitchen appliances that generate steam, as humidity can affect tablet integrity.

Levothyroxine Glenmark is taken orally, usually on an empty stomach, at least 30 minutes before breakfast or any other medication. Swallow the tablet whole with a full glass of water. Consistency in timing and food intake helps maintain stable absorption and thyroid hormone levels.

Serious risks include cardiac arrhythmias, angina or myocardial infarction, especially in patients with pre‑existing heart disease, and severe osteoporosis with long‑term overtreatment. Allergic reactions such as rash, swelling or breathing difficulty can also occur. Patients should report chest pain, rapid heartbeat, bone pain or any signs of an allergic response promptly.

Levothyroxine is contraindicated in individuals with known hypersensitivity to levothyroxine sodium or any of the tablet excipients. Patients with untreated adrenal insufficiency should not receive levothyroxine until adrenal function is corrected, as thyroid hormone can precipitate an adrenal crisis. Caution is advised for those with recent myocardial infarction or uncontrolled cardiac disease.